Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.23 USD | -3.85% | +28.64% | +853.82% |
Jun. 05 | GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients | CI |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 242M | Sales 2025 * | 276M | Capitalization | 686M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.83 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.48 x |
P/E ratio 2024 * |
-9.14
x | P/E ratio 2025 * |
-16.7
x | Employees | 1,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on GeneDx Holdings Corp.
1 day | -3.85% | ||
1 week | +28.64% | ||
Current month | +33.76% | ||
1 month | +34.38% | ||
3 months | +225.84% | ||
6 months | +1,539.38% | ||
Current year | +853.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 26.23 | -3.85% | 466,889 |
24-06-05 | 27.28 | +13.20% | 549,689 |
24-06-04 | 24.1 | +12.35% | 569,024 |
24-06-03 | 21.45 | +9.38% | 392,706 |
24-05-31 | 19.61 | -3.83% | 323,885 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+853.82% | 686M | |
-22.23% | 7.91B | |
+75.78% | 4.52B | |
+7.40% | 2.74B | |
-2.63% | 2.66B | |
-49.74% | 2.02B | |
-18.85% | 1.68B | |
-19.62% | 1.51B | |
+20.88% | 1.24B | |
-45.82% | 1.1B |
- Stock Market
- Equities
- WGS Stock